BioCentury
ARTICLE | Financial News

Xigen completes venture financing

November 23, 2009 8:00 AM UTC

Xigen S.A., Lausanne, Switzerland Business: Cardiovascular, Cancer Type: Venture financing Raised: CHF20 million ($19.8 million) Investor: Tilocor Life Sciences Note: The offering closed in 1Q09. ...